Study design and patient population
Cancer, cancer, breast cancer
CANCER, CANCER, INVASIVE BREAST CANCER, BREAST CANCER
The Feasibility of Introducing the Outcomes4Me Smartphone Navigation App (FIONA) trial is single-arm prospective study evaluating the feasibility of introducing a breast cancer education and navigation app into routine breast cancer care. The study was conducted among patients presenting for breast cancer care at the Massachusetts General Hospital Cancer Center or community-based satellite clinics. Eligible patients included English-speaking adults with invasive breast cancer stage I-IV presenting for a new diagnosis or follow-up visit who had access to an Apple or Android smartphone. Eligibility required that the patient was planning to receiving some form of active treatment for breast cancer (including surgery, radiation therapy, chemotherapy, endocrine therapy, or targeted therapy) within 4 weeks of study entry and was expected to continue follow-up within the cancer center. Eligible patients were identified by screening clinic lists and patients were recruited in-person or by telephone with electronic informed consent.After signing consent, participants were asked to download the Outcomes4Me app onto their smartphone with assistance from the research coordinator. Study usernames and emails were provided to each participant to create an anonymous app account. Participants were surveyed at baseline and at completion of the study at 12 weeks. In addition, participants received weekly app notifications to report any symptoms. The study was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board.